Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Moderna, Inc. (MRNA) had Return on Investments of -8.92% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$678.00M |
|
$-826.00M |
|
$452.00M |
|
$226.00M |
|
$1.53B |
|
$-857.00M |
|
$58.00M |
|
$-799.00M |
|
$-799.00M |
|
$-826.00M |
|
$-826.00M |
|
$-826.00M |
|
$-826.00M |
|
$-857.00M |
|
$-803.00M |
|
389.00M |
|
389.00M |
|
$-2.10 |
|
$-2.10 |
|
| Balance Sheet Financials | |
$6.54B |
|
$2.13B |
|
$5.79B |
|
$12.34B |
|
$1.99B |
|
$610.00M |
|
$1.70B |
|
$3.69B |
|
$8.65B |
|
$8.65B |
|
$8.65B |
|
394.00M |
|
| Cash Flow Statement Financials | |
$-1.87B |
|
$1.95B |
|
$593.00M |
|
$1.93B |
|
$2.60B |
|
$668.00M |
|
$483.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.29 |
|
-- |
|
-- |
|
0.07 |
|
0.07 |
|
33.33% |
|
-126.40% |
|
-126.40% |
|
-- |
|
-117.85% |
|
-121.83% |
|
$-2.06B |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
2.95 |
|
3.68 |
|
24.42 |
|
-9.55% |
|
-9.55% |
|
-6.69% |
|
|
Return on Investments |
-8.92% |
$21.95 |
|
$-5.31 |
|
$-4.81 |
|